COVID-19 Resource Centre


2021 ESCMID Websymposia on COVID-19

ESCMID is proud to announce that a series of 5 open-access websymposia will take place on Tuesday and Thursday afternoons, starting on Tuesday, 16 February 2021.

 

Visit the Websymposia webpage to learn more and to register.

 

 

ESCMID COVID-19 vaccination position statement

ESCMID has released a statement addressing the society's current position on COVID-19 vaccination.

The statement can be read here.

ESCMID Conference on Corona Virus Disease (ECCVID) – Emerging threats, emerging solutions

ESCMID is very pleased to announce that it will be hosting the first virtual congress specifically dedicated to COVID-19. The ESCMID Conference on Corona Virus Disease (ECCVID) will take place online from Wednesday 23rd to Friday 25th September 2020, and will cover all aspects of COVID-19.


The conference will host multiple tracks and a dedicated Programme Committee will work to secure a full and comprehensive scientific programme to cover a range of topics surrounding this emerging threat. More information will follow as the conference draws nearer.

 

Stay up to date on the conference website and by following us on our social media platforms like Twitter, Facebook and LinkedIn.


We hope you will join us for this incredible experience as we explore this global challenge.

 

COVID-19 Websymposium Series

COVID-19 Guidance Documents

EPASG Anti COVID-19 Survey

EPASG invites you to answer a short questionnaire with the aim of evaluating your actual "standard of care" for anti COVID-19 therapy use in your country and your department. The survey will allow us to assess the different practices worldwide for participants with direct patient care.

It will take no more than 10 minutes to complete this important survey to improve COVID-19 treatment. Do not hesitate, click here to participate!

 

Care of patients with liver disease during the COVID-19 pandemic: EASL-ESCMID Position Paper

ESCMID and EASL (The European Association for the Study of the Liver) have issued a Position Paper, providing recommendations for clinicians caring for patients with liver diseases during the current pandemic. This joint paper marks a huge collaborative effort focusing on managing patients with liver disease during the COVID-19 pandemic and strengthen the ties between our societies. This pandemic poses an enormous challenge for healthcare systems in affected areas, and the extent of chronic liver disease as a risk factor is still unclear. This paper provides some recommendations for hepatologists during this challenging time.

You can download the full paper here 

Other Resources